Hypersensitivity Reactions to Antibacterial Drugs in Infectious Mononucleosis

Pullen, H.; Wright, N.; Murdoch, J. McC.

doi:10.1016/s0140-6736(67)91893-4

Cited by 220 publications

(86 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The risk increases with age for many IDRs, such as isoniazidinduced liver injury; however, the liver injury associated with valproic acid is higher in infants (Zimmerman, 1999). The presence of a specific type of infection increases the risk of some IDRs, such as the increased risk of an amoxicillin-induced rash in patients with mononucleosis (Pullen et al, 1967) or the risk of a sulfonamide-induced hypersensitivity reaction in patients with AIDS (Mitsuyasu et al, 1983), but most IDRs occur in patients without any obvious interaction with a viral infection.…”

Section: Types and Clinical Picturementioning

confidence: 99%

Idiosyncratic Adverse Drug Reactions: Current Concepts

2013

View full text Add to dashboard Cite

Section: Types and Clinical Picturementioning

confidence: 99%

Idiosyncratic Adverse Drug Reactions: Current Concepts

2013

View full text Add to dashboard Cite

“…18 Most of these patients have a history of tolerating ampicillin in the past. On re-exposure to this medication in the absence of Epstein-Barr infection, they do not develop a rash, suggesting that active infection with the virus produces an interaction with the ampicillin and results in a fulminant drug reaction.…”

Section: Virus-drug Interactionmentioning

confidence: 99%

Neuroleptic malignant syndrome: a neuroimmunologic hypothesis

Anglin¹,

Rosebush²,

Mazurek³

2010

Canadian Medical Association Journal

View full text Add to dashboard Cite

“…Nearly all patients with infectious mononucleosis given 1.5 g or more of ampicillin will develop a rash (10), and an increased incidence of rash is known to occur with ampicillin therapy in patients with salmonella infections (15,16), cytomegalovirus infection (9), and chronic lymphatic leukemia (3).…”

Section: <0001)mentioning

confidence: 99%

Double-Blind Clinical Trials of Oral Cyclacillin and Ampicillin

Gold¹,

Hegarty²,

Deitch³

et al. 1979

Antimicrob Agents Chemother

View full text Add to dashboard Cite

A double-blind study was performed to compare the clinical response and the incidence of side effects in 2,581 patients administered ampicillin or cyclacillin for infections of the genitourinary or respiratory tract, infections of the skin and soft tissues, or for otitis media. There was no significant difference in clinical response and bacterial eradication. All side effects, including diarrhea and skin rash, were approximately twice as frequent in patients treated with ampicillin.Cyclacillin, 6-(1-aminocyclohexanecarboxamido)penicillanic acid, belongs to a new group of semisynthetic penicillins designated as aminocyclic penicillins. It is acid stable, has a low serum binding capacity of less than 25%, distributes well into tissues, and is more resistant to staphylococcal penicillinase than ampicillin (12).The in vitro activity of cyclacillin against gram-positive and gram-negative microorganisms is 25 to 50% below that of ampicillin (17). However, tests of in vitro susceptibility have been shown to be poor indicators of the therapeutic activity of this drug. Cyclacilhin is as effective as ampicillin in mice infected with penicillin-susceptible Staphylcoccus aureus, Streptococcus pyogenes, S. pneumoniae, and Haemophilus influenzae, less effective against Proteus mirabilis, and slightly more effective against Escherichia coli (17).Peak serum concentrations of cyclacillin occur earlier and are three to four times greater in magnitude (6, 17) than equal doses of ampicillin.Clinical trials also have indicated that cyclacillin and ampicillin are equally safe and effective for a variety of infections caused by susceptible gram-positive and gram-negative microorganisms (8, 13). However, these studies have suggested that patients treated with cyclacillin develop fewer gastrointestinal disorders and cutaneous rashes than patients treated with ampicillin (5, 13). Consequently, a large doubleblind study was performed involving more than 2,500 patients to compare the efficacy and safety of both antibiotics.MATERUILS AND METHODS A total of 2,581 patients were treated with cyclacillin or ampicillin. A culture for the identification of the etiological agent was made from the source of infection before treatment was started. Quantitative clean midstream urine cultures were made from the urine of patients with urinary tract infections, and a count of at least 1 x 105 organisms per ml was considered indicative of infection.Cyclacillin and ampicillin were prepared as identical tablets or oral suspensions. Medications were allocated at random so that both physician and patient were unaware of which drug was given. No concomitant antibiotics or anti-infective agents were administered. Approximately 75% of the patients treated with cyclacillin and ampicillin were adults. Of the adult patients, 39% were males, 61% were females, and the mean age was 44.7 years. Children treated with the cyclacillin suspension had a mean age of 2.8 years, and children treated with the ampicillin suspension had a mean age of 3.6 years. Adults were trea...

show abstract

Hypersensitivity Reactions to Antibacterial Drugs in Infectious Mononucleosis

Cited by 220 publications

References 8 publications

Idiosyncratic Adverse Drug Reactions: Current Concepts

Idiosyncratic Adverse Drug Reactions: Current Concepts

Neuroleptic malignant syndrome: a neuroimmunologic hypothesis

Double-Blind Clinical Trials of Oral Cyclacillin and Ampicillin

Contact Info

Product

Resources

About